Lee, P.Y.; Shih, C.-Y.; Cheng, C.-Y.; Ho, H.; Chen, Y.-L.; Chang, C.-J.
The Prognostic Value of CIP2A and Its Association with CD31, E-Cadherin, and pAMPK in Lung Cancer. Int. J. Mol. Sci. 2025, 26, 8362.
https://doi.org/10.3390/ijms26178362
AMA Style
Lee PY, Shih C-Y, Cheng C-Y, Ho H, Chen Y-L, Chang C-J.
The Prognostic Value of CIP2A and Its Association with CD31, E-Cadherin, and pAMPK in Lung Cancer. International Journal of Molecular Sciences. 2025; 26(17):8362.
https://doi.org/10.3390/ijms26178362
Chicago/Turabian Style
Lee, Peng Yu, Ching-Yu Shih, Chiao-Yin Cheng, Hua Ho, Yen-Lin Chen, and Chih-Jung Chang.
2025. "The Prognostic Value of CIP2A and Its Association with CD31, E-Cadherin, and pAMPK in Lung Cancer" International Journal of Molecular Sciences 26, no. 17: 8362.
https://doi.org/10.3390/ijms26178362
APA Style
Lee, P. Y., Shih, C.-Y., Cheng, C.-Y., Ho, H., Chen, Y.-L., & Chang, C.-J.
(2025). The Prognostic Value of CIP2A and Its Association with CD31, E-Cadherin, and pAMPK in Lung Cancer. International Journal of Molecular Sciences, 26(17), 8362.
https://doi.org/10.3390/ijms26178362